Compare KEX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KEX | LNTH |
|---|---|---|
| Founded | 1921 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.9B |
| IPO Year | 1994 | 2014 |
| Metric | KEX | LNTH |
|---|---|---|
| Price | $133.23 | $77.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $127.75 | $83.20 |
| AVG Volume (30 Days) | 522.5K | ★ 834.7K |
| Earning Date | 04-30-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.92 | N/A |
| EPS | ★ 6.33 | 3.41 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $4.19 | N/A |
| Revenue Next Year | $7.56 | $13.47 |
| P/E Ratio | ★ $21.14 | $23.26 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $79.52 | $47.27 |
| 52 Week High | $134.69 | $111.29 |
| Indicator | KEX | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 66.63 | 75.23 |
| Support Level | $111.10 | $77.38 |
| Resistance Level | N/A | $84.84 |
| Average True Range (ATR) | 3.76 | 2.91 |
| MACD | 0.54 | 0.59 |
| Stochastic Oscillator | 91.46 | 79.36 |
Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's revenue is generated from the Marine Transportation segment.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.